ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,887Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 917

$516K Total Retail Price of All Prescriptions

Rank: 111 out of 917

438 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,908 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 398 368 1 1
SIMVASTATIN 362 331 2 2
LEVOTHYROXINE SODIUM 343 301 3 3
FUROSEMIDE 268 225 4 7
OMEPRAZOLE 261 235 5 4
CITALOPRAM HBR 191 186 6 15
METOPROLOL TARTRATE 189 182 7 11
WARFARIN SODIUM 178 172 8 10
METFORMIN HCL 175 174 9 8
AMLODIPINE BESYLATE 170 164 10 5
DONEPEZIL HCL 170 170 10 32
HYDROCODONE-ACETAMINOPHEN 151 142 S3 12 6
POTASSIUM CHLORIDE 150 134 13 16
GLIPIZIDE 147 144 14 40
ATENOLOL 140 135 15 12
GABAPENTIN 132 106 16 17
METOPROLOL SUCCINATE 124 113 17 18
FLUTICASONE PROPIONATE 123 113 18 26
HYDROCHLOROTHIAZIDE 114 100 19 9
LOSARTAN POTASSIUM 110 106 20 13
TAMSULOSIN HCL 103 72 21 25
TRAZODONE HCL 103 98 21 22
ALENDRONATE SODIUM 98 86 23 23
PRAVASTATIN SODIUM 96 86 24 20
LANTUS SOLOSTAR 90 60 25 63
LOVASTATIN 90 74 25 19
PREDNISONE 80 67 27 34
PROAIR HFA 79 74 28 35
CARVEDILOL 78 77 29 33
TERAZOSIN HCL 77 66 30 108
ATORVASTATIN CALCIUM 71 60 31 14
DILTIAZEM 24HR CD 71 68 31 95
TRAMADOL HCL 67 54 33 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 64 34 116
PANTOPRAZOLE SODIUM 63 63 35 44
CRESTOR 63 59 35 30
ADVAIR DISKUS 62 58 37 47
RISPERIDONE 60 57 38 51
OXYCODONE-ACETAMINOPHEN 60 58 S2 38 46
ZOLPIDEM TARTRATE 58 51 40 21
JANUVIA 58 58 40 81
SPIRIVA 57 45 42 45
NEXIUM 56 47 43 60
VENLAFAXINE HCL ER 54 21 44 78
OXYBUTYNIN CHLORIDE 52 52 45 76
NAMENDA 51 51 46 43
AZITHROMYCIN 51 45 46 61
ROPINIROLE HCL 51 39 46 88
SINGULAIR 50 47 49 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.